SU1421302A1 - Method of determining the rate of absorption of glucose with organism - Google Patents
Method of determining the rate of absorption of glucose with organism Download PDFInfo
- Publication number
- SU1421302A1 SU1421302A1 SU864070164A SU4070164A SU1421302A1 SU 1421302 A1 SU1421302 A1 SU 1421302A1 SU 864070164 A SU864070164 A SU 864070164A SU 4070164 A SU4070164 A SU 4070164A SU 1421302 A1 SU1421302 A1 SU 1421302A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- glucose
- blood
- electrical resistance
- rate
- measured
- Prior art date
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims description 25
- 239000008103 glucose Substances 0.000 title claims description 25
- 238000000034 method Methods 0.000 title claims description 10
- 238000010521 absorption reaction Methods 0.000 title claims description 6
- 239000008280 blood Substances 0.000 claims description 21
- 210000004369 blood Anatomy 0.000 claims description 21
- 230000004190 glucose uptake Effects 0.000 claims description 3
- 230000006641 stabilisation Effects 0.000 claims 1
- 238000011105 stabilization Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 description 5
- 230000000747 cardiac effect Effects 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 238000001631 haemodialysis Methods 0.000 description 3
- 230000000322 hemodialysis Effects 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Description
(21)4070164/28-14(21) 4070164 / 28-14
(22)28.04.86(22) 04/28/86
(46) 07.09.88. Бнш. № 33(46) 09/07/88. Bnsh. Number 33
(71)Всесоюзный научный центр хирур-, гии АМН СССР . ;(71) All-Union Scientific Center of Surgery, Medical Academy of Medical Sciences of the USSR. ;
(72)В.В.Кислухин и Н.М..Кривицкий(72) V.V. Kislukhin and N.M.Krivitsky
(53)612.015 (088.8)(53) 612.015 (088.8)
(56) Ермоленко В.М. Хронический гемодиализ . - М.: Медицина 1982, с. 203204 . I(56) Ermolenko V.M. Chronic hemodialysis. - M .: Medicine 1982, p. 203204. I
(54)СПОСОБ ОПРЕДЕЛЕНИЯ СКОРОСТИ ПОГЛОЩЕНИЯ ГЛЮКОЗЫ ОРГАНИЗМОМ(54) METHOD FOR DETERMINING THE GLUCOSE ABSORPTION RATE BY THE ORGANISM
(57) Изобретение относитс к медицине и медицинской технике, касаетс способов определени параметров орга низма методом разведени индикаторов . Цель изобретени -сокращение времени исследовани с одновременным повышением селективности. Дл этого(57) The invention relates to medicine and medical technology, to methods for determining the parameters of an organism by the method of dilution of indicators. The purpose of the invention is to shorten the research time while simultaneously increasing the selectivity. For this
в пробе крови из артерии определ ют концентрацию глюкозы и осмол рность. Ввод т электроды в артериальное русло и измер ют электрическое сопротивление (ЭС) крови, затем внутривенно капельно ввод т изоосмотггческий р-р глюкозы и измер ют значение повьше- ни уровн ЭС крови. Далее повторно внутривенно ввод т изоосмотический р-р глюкозы, регистрируют кривую ЭС крови. Скорость поглощени глюкозы (v) рассчитывают по формуле v-CE-C- (S/4Z) (g/U), где СВ-измеренный сердечный выброс, С - концентраци глюкозы в артериальной крови, S площадь под кривой первого прохождени ; 4 Z - приращение ЭС крови; g - объемна скорость канального введени ; V - объем введенной импульсной глюкозы.in the arterial blood sample, the glucose concentration and osmolarity are determined. Electrodes are injected into the arterial bed and the electrical resistance (ES) of the blood is measured, then the isosmoticus solution of glucose is administered intravenously and the value of the increase in the ES level of the blood is measured. Next, the isoosmotic solution of glucose is re-intravenously injected, and the blood ES curve is recorded. The glucose uptake rate (v) is calculated using the formula v-CE-C- (S / 4Z) (g / U), where CB is the measured cardiac output, C is the concentration of glucose in arterial blood, S is the area under the first-pass curve; 4 Z is the increment of blood ES; g is the volumetric rate of channel injection; V is the volume of the input pulsed glucose.
SSSS
Изобретение относитс к медицине и медицинской технике, а именно к способам определени параметров организма методом разведени индикато- The invention relates to medicine and medical technology, and in particular to methods for determining the parameters of the body by the method of dilution of indicative
рОВоROVO
: Целью изобретени вл етс сокра- времени исследовани с одновременным повышением селективности.A: The purpose of the invention is to shorten the time of the study while simultaneously increasing the selectivity.
Способ осуществл ют следующим об- разом,The method is carried out as follows.
: Берут пробу крови из артерии и определ ют концентрадаю глюкозы и ос- Цол рность, Ввод т электроды в артериальное русло и измер ют электри- веское сопротивление. Осуществл ют йепрерЫвную внутривенную инъекцию , зоосмотического раствора глюкозы в. течение 1--3 мин, регистрируют установившеес приращение электрического Сопротивлени .крови, т.е. ситуаидло когда количество поглощаемой глюкозы Сравниваетс с количеством вводимой, и измер ет приращение электрического сопротивлени крови d Z. Далее .осуще- ствл ют внутривенную импульсную инъекцию нзоосмотической глюкозы (10-20 м ) и регистрируют кривую изменени электрического сопротивлени кровиJ под которой определ ют площад S«.Сердечный выброс определ ют любым известным способом (по Кубичеку.тер- моделютором5 разведением импеданс- ных индикаторов). Далее по формуле накод т скорость v поглощени глюко зы: A blood sample is taken from the artery and the glucose concentration and os-colony are determined. Electrodes are introduced into the arterial bed and the electrical resistance is measured. Carry out intravenous injection of a glucose zoosmotic solution. for 1--3 min, register the steady-state increment of the electrical resistance of the blood, i.e. when the amount of absorbed glucose is compared with the amount injected, and measures the increment of the electrical resistance of the blood d Z. Next, an intravenous pulsed injection of nzoosmotic glucose (10-20 m) is performed and the curve of the electrical resistance of the blood under which the area S is determined is measured. ". The cardiac output is determined by any known method (according to the Cubichek-modeler5 dilution of impedance indicators). Further, according to the formula, the speed v of glucose absorption
РПГ2-03, кривые регистрировали .самописцем ,RPG2-03, the curves were recorded.
Вначале вз ли пробу крови и определили стандартными методами концент рацию сахара С ± 1,04 г/л и осмол р- . ность - 307 мосмоль/л, поскольку осмол рность нормальна , около 300 мосмоль/л, то использовали стан- дартньш 5%-ный раствор глюкозы, В течение 2 мин вводили 100 мл глюкозы , скорость ввода составила 50 мл/мин (2,5 г/мин), при этом прирщение электрического сопротивлени составило А Z 15 дм. Далее ввели внутривенно импульсно 20 мп 5%-ного раствора глюкозы и расчитали площадь под кривой первого прохождени S 20 м/мин. Сердечный выброс определили методом разведени электроимпе- дансных индикаторов ,5 л/мин. Тогда скорость поглощени глюкозы организмом будетFirst, a blood sample was taken and the concentration of sugar C ± 1.04 g / l and osmol p- was determined by standard methods. 307 mosmol / l, since the osmolarity is normal, about 300 mosmol / l, then a standard 5% glucose solution was used. For 2 min, 100 ml of glucose was injected, the injection rate was 50 ml / min (2.5 g / min), while the increase in electrical resistance was A Z 15 dm. Then, a pulse of 20 mp of 5% glucose solution was injected intravenously and the area under the first pass curve S 20 m / min was calculated. Cardiac output was determined by dilution of electrical impedance indicators, 5 L / min. Then the rate of absorption of glucose by the body will be
.V CB.C.-|- -S2 ,25 г/мин..V CB.C.- | - -S2, 25 g / min.
Таким образом, предлагаемый спог соб позвол ет в течение 5 мин определить скорость поглощени глюкозы организмом, причем определ ть этот пара-метр многократно, и тем самым определ ть энергетический статус (Организма у .больных реанимации, гемодиализа и т.д.Thus, the proposed method allows for 5 minutes to determine the rate of glucose absorption by the body, and to determine this parameter repeatedly, and thereby determine the energy status (of the organism in patients with resuscitation, hemodialysis, etc.
V СВ-С --- А ZV CB-C --- A Z
VV
где СВ - сердечный выбросэ измерен- ддwhere CB is cardiac output, measured dd
ный известным способом; С концентраци глюкозы в артериал: ьной крови| S - площадь под кривой первогоin a known manner; With arterial glucose concentration: blood | S - the area under the curve of the first
прохоходени ;45prohohodeni; 45
U Z - приращение электрическогоU Z - electric increment
сопротивлени крови, g - объемна скорость капельного введени глюкозы; - объем введенной импульсной .blood resistance, g is the volumetric rate of drip glucose; - the volume of the input pulse.
глюкозы,glucose,
Пример. Диагноз -. хроническа почечна недостаточность. Исследова- , ни проводили во врем сеанса гемодиализа , В качестве электродов исполь- . зовали две инъекционные иглы, которые 5з;вели в майжетку артериальной магистрали. Электрическое сопротивле ние крови измер ли реоплетизмографомExample. The diagnosis is. chronic renal failure. Investigations, nor performed during a hemodialysis session, used as electrodes. two injection needles, which were 5z, were led; they were led to the artery trunk vest. The electrical resistance of the blood was measured with a reoplethismograph.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU864070164A SU1421302A1 (en) | 1986-04-28 | 1986-04-28 | Method of determining the rate of absorption of glucose with organism |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU864070164A SU1421302A1 (en) | 1986-04-28 | 1986-04-28 | Method of determining the rate of absorption of glucose with organism |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1421302A1 true SU1421302A1 (en) | 1988-09-07 |
Family
ID=21238679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU864070164A SU1421302A1 (en) | 1986-04-28 | 1986-04-28 | Method of determining the rate of absorption of glucose with organism |
Country Status (1)
| Country | Link |
|---|---|
| SU (1) | SU1421302A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5487384A (en) * | 1993-02-25 | 1996-01-30 | Blue Marble Research, Inc. | Kinematic assay of plasma glucose concentration without blood sampling |
-
1986
- 1986-04-28 SU SU864070164A patent/SU1421302A1/en active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5487384A (en) * | 1993-02-25 | 1996-01-30 | Blue Marble Research, Inc. | Kinematic assay of plasma glucose concentration without blood sampling |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sowton et al. | Hemodynamic changes after beta adrenergic blockade | |
| DUKE et al. | The hemodynamic response to chronic anemia | |
| Kelly et al. | Thioridazine hydrochloride (Mellaril): its effect on the electrocardiogram and a report of two fatalities with electrocardiographic abnormalities | |
| Abraham et al. | Reversal of pulmonary hypertension by prolonged oxygen administration to patients with chronic bronchitis | |
| UDHOJI et al. | Hemodynamic and metabolic studies on shock associated with bacteremia: observations on 16 patients | |
| Rosenblum et al. | Dopamine in man: cardiorenal hemodynamics in normotensive patients with heart disease | |
| Quail et al. | Thoracic resistivity for stroke volume calculation in impedance cardiography | |
| Block et al. | Chronic oxygen therapy: Treatment of chronic obstructive pulmonary disease at sea level | |
| Williams et al. | Dynamic measurement of human capillary blood pressure | |
| Lal et al. | Cardiovascular and respiratory effects of morphine and pentazocine in patients with myocardial infarction | |
| Sackner et al. | The site of pulmonary vasomotor activity during hypoxia or serotonin administration. | |
| Chapman et al. | Effects of graded reduction of brain blood flow on ventilation in unanesthetized goats | |
| FOLTZ et al. | The effects of intravenous aminophylline upon the coronary blood-oxygen exchange | |
| PAYKOÇ et al. | The excretion of sodium trichloracetate | |
| SU1421302A1 (en) | Method of determining the rate of absorption of glucose with organism | |
| Roger et al. | Effects of oxygen breathing and erythropoietin on hypoxic vasodilation in uremic anemia | |
| Larsen et al. | The effect of urea and mannitol on cochlear blood flow | |
| Facey et al. | Mechanism and treatment of shock associated with acute pancreatitis | |
| Eidelman et al. | Absence of cerebral vasoconstriction with hyperventilation in tetraplegic man: evidence for neurogenic control of cerebral circulation | |
| Lee et al. | The effects of magnesium sulfate infusion on blood pressure and vascular responsiveness during pregnancy | |
| Greenspan et al. | Isotope circulation studies in congenital heart disease | |
| Balasubramanian et al. | Effect of digoxin and diuretics on high altitude left ventricular dysfunction. | |
| Sambhi et al. | Effect of pressor amines on cardiac output in patients with acute hypotension | |
| Parin et al. | An Outline of the Clinical Physiology of the Circulation | |
| Fitzgerald et al. | A case of increased platelet anti-heparin factor in a patient with Raynaud's phenomena and gangrene, treated by aspirin |